Aaron Calodney, MD
Pain Medicine · Tyler, TXNPI 1396707121
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Nevro Corp. at 26.6% of the total. Reporting peaked in 2019 at $86,683 and has fallen 88.6% since, to $9,882 in 2025. Among pain medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 700 payments — averaging $423.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$79K
- Medtronic$65K
- Stryker$51K
- Stratus Medical, LLC$31K
- Boston Scientific$26K
- Globus Medical$11K
- plus $33K from 30 others
Across 347 payments — averaging $7926.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$1.6M
- Boston Scientific$509K
- Nevro Corp.$382K
- Nalu Medical, Inc.$107K
- Saluda Medical Americas, Inc.$63K
- Relievant Medsystems, Inc.$39K
- plus $34K from 5 others
What the payments were for
- Consulting fees$106,59336%
- Speaking & faculty fees$150,15551%
- Travel & lodging$14,1285%
- Food & beverage$24,2538%
- Education$1,2020%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 124 | $78,883 |
| Medtronic(2 entities) | 97 | $65,103 |
| Stryker | 51 | $51,053 |
| Stratus Medical, LLC | 3 | $30,780 |
| Boston Scientific | 43 | $25,541 |
| Globus Medical | 20 | $11,474 |
| Vertos Medical, Inc. | 23 | $9,132 |
| Saluda Medical Americas, Inc. | 17 | $7,062 |
| Painteq LLC | 13 | $6,171 |
| Abbott | 167 | $2,979 |
| Relievant Medsystems, Inc. | 11 | $2,054 |
| Nalu Medical, Inc. | 29 | $950 |
| Wenzel Spine, Inc. | 2 | $612 |
| Vertiflex, Inc. | 7 | $553 |
| Amgen | 19 | $449 |
| Stimwave Technologies Incorporated | 5 | $428 |
| Spinal Simplicity, LLC | 5 | $386 |
| Si-bone, Inc. | 4 | $337 |
| Biotissue Holdings Inc. | 5 | $304 |
| Alevio, LLC | 2 | $277 |
| Biotronik NRO, Inc. | 7 | $249 |
| Averitas Pharma Inc. | 5 | $197 |
| Biohaven Pharmaceuticals, Inc. | 8 | $189 |
| Cerapedics Inc. | 1 | $155 |
| Vy Spine LLC | 1 | $149 |
| AbbVie(2 entities) | 8 | $146 |
| SPR Therapeutics, Inc | 2 | $129 |
| Curonix LLC | 2 | $115 |
| Providence Medical Technology, Inc. | 1 | $112 |
| Tersera Therapeutics LLC | 5 | $102 |
| Bioventus LLC | 3 | $71 |
| Pfizer | 4 | $52 |
| Lundbeck LLC | 2 | $46 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $44 |
| Amniox Medical, Inc. | 1 | $25 |
| Novartis | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza Spinal Cord Stimulation System$66,257
- Nimbus$30,750
- INTELLIS$29,692
- SUPERION$17,405
- MULTIGEN 2$12,406
- Viacell$10,500
- SPINEJACK$9,915
- NEW PRODUCT DEVELOPMENT$9,300
- mild Device Kit$8,876
- Omnia$8,562
- IVS - MULTIGEN RF$7,100
- Intracept$6,901
- Evoke SCS$6,858
- IVS - MULTIGEN 2RF$6,631
- PAINTEQ$6,037
- IVS - RF CANNULAE/NEEDLES$4,900
- RESTORE$3,932
- PCD$3,600
- SYNCHROMED$3,379
- GENERAL PAIN MANAGEMENT$3,127
How this compares
$296,329 in reported general payments places this provider in the 95th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 699 | $15,993 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 488 | $10,526 |
| Aimovig AutoinjectorErenumab-Aooe | 12 | $7,456 |
| Gabapentin | 203 | $3,071 |
| Pregabalin | 72 | $1,187 |
| Celecoxib | 19 | $1,042 |
| Duloxetine Hcl | 21 | $864 |
| Tramadol Hcl | 99 | $724 |
| Tizanidine Hcl | 98 | $608 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 51 | $557 |
| Baclofen | 17 | $462 |
| Morphine Sulfate | 14 | $414 |
| Diclofenac Sodium | 14 | $290 |
| Meloxicam | 45 | $225 |
| Topiramate | 16 | $181 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Tyler
- Melissa MurphyGrapevine$653K
- Shiraz YazdaniLubbock$514K
- Candice BurnetteSugar Land$265K
- Ashley Bailey-ClassenFort Worth$244K
- Grant ChenHouston$175K
- Gunjan PatelHouston$166K
- Anthony BergRockwall$165K
- Puneet SayalCorpus Christi$153K
- Eduardo GarciaWebster$147K
- Jaideep MehtaHouston$134K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.